Current Cancer Drug Targets

Current Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang (UH Drug Discovery Institute). The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry. Current Cancer Drug Targets publishes original research reports, review papers, and rapid communications ("letters").[1]

Current Cancer Drug Targets
DisciplineOncology
LanguageEnglish
Edited byRuiwen Zhang
Publication details
History2001–present
Publisher
Frequency11/year
2.912 (2019)
Standard abbreviations
ISO 4Curr. Cancer Drug Targets
Indexing
CODENCCDTB9
ISSN1568-0096 (print)
1873-5576 (web)
OCLC no.48132748
Links

Abstracting and indexing

edit

Current Cancer Drug Targets is abstracted and indexed in:[2]

According to the Journal Citation Reports, the journal has a 2019 impact factor of 2.912.[3]

References

edit
  1. ^ "Journal overview". Current Cancer Drug Targets. Bentham Science Publishers. June 2021. Retrieved 2021-06-14.
  2. ^ "List of indexing services". Current Cancer Drug Targets. Bentham Science Publishers. June 2021. Archived from the original on 2011-08-01. Retrieved 2011-08-04.
  3. ^ "Journals Ranked by Impact: Oncology". 2019 Journal Citation Reports. Clarivate. 2020.{{cite book}}: CS1 maint: postscript (link)
edit